Evidence map›Paper›PMID 28418031›Full record

Trial reportScientific reports2017

Serum Concentration of HDL Particles Predicts Mortality in Acute Heart Failure Patients.

Ines Potočnjak, Vesna Degoricija, Matias Trbušić, Gudrun Pregartner, Andrea Berghold, Gunther Marsche, Saša Frank

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Heart failure etiology and lipoprotein subfractions: Insight from the SMARTEX-HF study.International journal of cardiology. Heart & vasculature · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. HDL Composition, Heart Failure, and Its Comorbidities.Frontiers in cardiovascular medicine · 2022
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ines PotočnjakUniversity Hospital Centre Sisters of Charity, Department of Medicine, Zagreb, Croatia.
Vesna DegoricijaUniversity Hospital Centre Sisters of Charity, Department of Medicine, Zagreb, Croatia.
Matias TrbušićUniversity Hospital Centre Sisters of Charity, Department of Medicine, Zagreb, Croatia.
Gudrun PregartnerInstitute for Medical Informatics, Statistics und Documentation, Medical University of Graz, Graz, Austria.
Andrea BergholdInstitute for Medical Informatics, Statistics und Documentation, Medical University of Graz, Graz, Austria.
Gunther MarscheInstitute of Experimental and Clinical Pharmacology, Medical University of Graz, Austria.
Saša FrankBioTechMed-Graz, Austria.
Medical University of Graz · ATSisters of Charity Hospital · HRUniversity of Zagreb · HR

Funding

Austrian Science Fund FWF P 22976Austrian Science Fund FWF P 27166
6 · The paper itself

Abstract

Clinical studies have shown that assessing circulating concentrations of high-density lipoprotein (HDL) particles by nuclear magnetic resonance (NMR) spectroscopy is superior to HDL-cholesterol in predicting cardiovascular risk. We tested the hypothesis that circulating concentrations of HDL particles predict 3-month mortality of patients with acute heart failure (AHF). Out of 152 included patients, 52% were female, additionally the mean patient age was 75.2 ± 10.3 years, and three-month mortality was 27%. Serum lipoprotein profile at admission was determined by NMR spectroscopy. Univariate logistic regression analyses revealed a significant inverse association of total (odds ratio (OR) 0.38 per 1-SD increase, 95% confidence interval (CI) 0.23-0.60, p < 0.001) and small HDL particle concentrations (OR 0.35 per 1-SD increase, 95% CI 0.19-0.60, p < 0.001) with 3-month mortality, whereas concentrations of large HDL particles (p = 0.353) or HDL-cholesterol (p = 0.107) showed no significant association. After adjustment for age, sex, mean arterial pressure, low-density lipoprotein cholesterol, glomerular filtration rate, urea, and N-terminal pro-brain natriuretic peptide, both the total and small HDL particle concentrations remained significantly associated with 3-month mortality. Based on our results, we conclude that total and small HDL particle concentrations strongly and independently predict 3-month mortality in AHF patients.

Indexed as

Heart FailureAgedAged, 80 and overCholesterol, HDLCholesterol, LDLDisease-Free SurvivalFemaleHumansMaleMiddle AgedProspective StudiesSurvival RateCholesterol, HDLCholesterol, LDL

Identifiers

PMID28418031
PMCPMC5394530
OpenAlexW2606428603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.